专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20120114690A1 EXTERNAL USE COMPOSITION FOR SKIN 有权
标题翻译：外用皮肤组合物
公开(公告)号：US20120114690A1
公开(公告)日：2012-05-10
申请号：US13289648
申请日：2011-11-04
申请人： Hifumi OHISHI , Keizou Ohishi , Tetsuya Oishi , Hisanori Tani
发明人： Hifumi OHISHI , Keizou Ohishi , Tetsuya Oishi , Hisanori Tani
IPC分类号： A61K36/03 , A61K38/02 , A61P17/00 , A61K36/185 , A61K36/704
CPC分类号： A61K36/03 , A61K35/57 , A61K36/185 , A61K36/704 , A61K38/02 , A61K2300/00
摘要： The present disclosure provides an external use composition for skin comprising a tarajo holly leaf extract and a Japanese knotweed leaf extract, a brown algae extract and an egg shell membrane derived peptide (ESM-P) having a molecular mass of 3 kDa or higher. The composition according to the present invention can be used to treat a disease or condition of skin relating to a filaggrin metabolism anomaly, such as atopic dermatitis. The composition according to the present invention can be used specifically for the therapy of atopic dermatitis.
摘要翻译：本公开内容提供了一种皮肤外用组合物，其包含塔拉霍氏叶提取物和日本藜草提取物，褐藻提取物和分子量为3kDa以上的蛋壳膜衍生肽（ESM-P）。根据本发明的组合物可用于治疗与丝聚蛋白代谢异常有关的皮肤疾病或病症，例如特应性皮炎。根据本发明的组合物可以专门用于治疗特应性皮炎。

2. 发明授权

US08425949B2 External use composition for skin 有权
标题翻译：皮肤外用组合物
公开(公告)号：US08425949B2
公开(公告)日：2013-04-23
申请号：US13289648
申请日：2011-11-04
申请人： Hifumi Ohishi , Keizou Ohishi , Tetsuya Oishi , Hisanori Tani
发明人： Hifumi Ohishi , Keizou Ohishi , Tetsuya Oishi , Hisanori Tani
IPC分类号： A01N65/00
CPC分类号： A61K36/03 , A61K35/57 , A61K36/185 , A61K36/704 , A61K38/02 , A61K2300/00
摘要： The present disclosure provides an external use composition for skin comprising a tarajo holly leaf extract and a Japanese knotweed leaf extract, a brown algae extract and an egg shell membrane derived peptide (ESM-P) having a molecular mass of 3 kDa or higher. The composition according to the present invention can be used to treat a disease or condition of skin relating to a filaggrin metabolism anomaly, such as atopic dermatitis. The composition according to the present invention can be used specifically for the therapy of atopic dermatitis.
摘要翻译：本公开内容提供了一种皮肤外用组合物，其包含塔拉霍氏叶提取物和日本藜草提取物，褐藻提取物和分子量为3kDa以上的蛋壳膜衍生肽（ESM-P）。根据本发明的组合物可用于治疗与丝聚蛋白代谢异常有关的皮肤疾病或病症，例如特应性皮炎。根据本发明的组合物可以专门用于治疗特应性皮炎。

3. 发明授权

US06855345B2 Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions 失效
标题翻译： Morinda citrifolia对糖尿病及其相关病症的预防和治疗作用
公开(公告)号：US06855345B2
公开(公告)日：2005-02-15
申请号：US10286167
申请日：2002-11-01
申请人： Claude Jarakae Jensen , Afa Kehaati Palu , Hifumi Ohishi , Hisanori Tani
发明人： Claude Jarakae Jensen , Afa Kehaati Palu , Hifumi Ohishi , Hisanori Tani
IPC分类号： A61K35/68 , A61K36/746
CPC分类号： A61K36/746
摘要： The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
摘要翻译：本发明的特征在于其独特的天然配方和方法，其用于治疗和预防糖尿病，或者改进预防糖尿病，通过提供由一种或多种加工的Morinda citrifolia产品配制的营养组合物或治疗剂，其衍生自印度桑树厂。 Morinda citrifolia特别适用于治疗II型糖尿病。海巴戟天产品优选是叶提取物，但也可以是果汁，果汁，膳食纤维或其它类似形式的形式，并且被掺入适合于体内治疗患者的各种载体或营养组合物中。该制品也可以将其他食品结合到食品中，例如果汁，膳食补充剂，维生素和矿物质等。

4. 发明申请

US20050147700A1 Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions 失效
公开(公告)号：US20050147700A1
公开(公告)日：2005-07-07
申请号：US10993883
申请日：2004-11-19
申请人： Claude Jensen , Afa Palu , Hifumi Ohishi , Hisanori Tani
发明人： Claude Jensen , Afa Palu , Hifumi Ohishi , Hisanori Tani
IPC分类号： A61K35/68 , A61K36/746 , A61K35/78
CPC分类号： A61K36/746
摘要： The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

5. 发明授权

US07186422B2 Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions 失效
标题翻译： Morinda citrifolia对糖尿病及其相关病症的预防和治疗作用
公开(公告)号：US07186422B2
公开(公告)日：2007-03-06
申请号：US10993883
申请日：2004-11-19
申请人： Claude Jarakae Jensen , Afa Kehaati Palu , Hifumi Ohishi , Hisanori Tani
发明人： Claude Jarakae Jensen , Afa Kehaati Palu , Hifumi Ohishi , Hisanori Tani
IPC分类号： A61K36/746 , A61K36/00
CPC分类号： A61K36/746
摘要： The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
摘要翻译：本发明的特征在于其独特的天然配方和方法，其用于治疗和预防糖尿病，或者改进预防糖尿病，通过提供由一种或多种加工的Morinda citrifolia产品配制的营养组合物或治疗剂，其衍生自印度桑树厂。 Morinda citrifolia特别适用于治疗II型糖尿病。海巴戟天产品优选是叶提取物，但也可以是果汁，果汁，膳食纤维或其它类似形式的形式，并且被掺入适合于体内治疗患者的各种载体或营养组合物中。该制品也可以将其他食品结合到食品中，例如果汁，膳食补充剂，维生素和矿物质等。

6. 发明申请

US20070178181A1 PREVENTATIVE AND TREATMENT EFFECTS OF MORINDA CITRIFOLIA ON DIABETES AND ITS RELATED CONDITIONS 审中-公开
标题翻译：莫鞭草对糖尿病及其相关病症的预防和治疗效果
公开(公告)号：US20070178181A1
公开(公告)日：2007-08-02
申请号：US11553323
申请日：2006-10-26
申请人： Claude Jensen , Afa Palu , Hifumi Ohishi , Hisanori Tani
发明人： Claude Jensen , Afa Palu , Hifumi Ohishi , Hisanori Tani
IPC分类号： A61K36/746
CPC分类号： A61K36/746
摘要： The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
摘要翻译：本发明的特征在于其独特的天然配方和方法，其用于治疗和预防糖尿病，或者改进预防糖尿病，通过提供由一种或多种加工的Morinda citrifolia产品配制的营养组合物或治疗剂，其衍生自印度桑树厂。 Morinda citrifolia特别适用于治疗II型糖尿病。海巴戟天产品优选是叶提取物，但也可以是果汁，果汁，膳食纤维或其它类似形式的形式，并且被掺入适合于体内治疗患者的各种载体或营养组合物中。该制品也可以将其他食品结合到食品中，例如果汁，膳食补充剂，维生素和矿物质等。

7. 发明申请

US20110123640A1 NOVEL FERMENTED MILK PRODUCT AND USE THEREOF 审中-公开
标题翻译：新型发酵奶制品及其用途
公开(公告)号：US20110123640A1
公开(公告)日：2011-05-26
申请号：US12996917
申请日：2009-06-08
申请人： Yoshie Yabumoto , Hisanori Tani , Kazuto Suzuki , Tetsumi Yabumoto , Yuriko Yoshida
发明人： Yoshie Yabumoto , Hisanori Tani , Kazuto Suzuki , Tetsumi Yabumoto , Yuriko Yoshida
IPC分类号： A61K35/20 , C12N1/20 , A61P1/00 , A61P31/00 , A23C9/127
CPC分类号： A23L3/3463 , A23C9/127 , A23L33/135 , A23Y2220/47 , A61K35/74 , A61K36/064 , A61K2300/00
摘要： Disclosed is a fermented milk product, which is useful for the promotion of good health. The fermented milk product is produced by fermenting a milk raw material with a combination of microorganisms consisting of (1) Lactobacillus kefiri and (2) at least one microorganism selected from the group consisting of Kazachstania turicensis, Kazachstania unispora and Kluyveromyces marxianus. Preferably, the fermented milk product is produced by fermenting the milk raw material with a combination of microorganisms consisting of at least Lactobacillus kefiri strain P-IF, Lactobacillus kefiri strain P-B1, Kazachstania turicensis strain P-Y3, Kazachstania unispora strain P-Y4 and Kluyveromyces marxianus strain P-Y5.
摘要翻译：公开了一种用于促进身体健康的发酵乳制品。发酵乳产品是通过用（1）乳酸杆菌和（2）至少一种选自以下的微生物组合的微生物发酵牛奶原料来制造的：（2）至少一种选自哈萨克斯坦土地，哈萨克斯坦和马克斯克鲁维酵母的微生物。优选地，发酵乳产品是通过用至少包含克氏杆菌菌株P-IF，乳杆菌菌株P-B1，卡斯卡齐亚山茱萸菌株P-Y3，单孢子菌株P-Y4组成的微生物组合来发酵乳制品马克斯克鲁维酵母菌株P-Y5。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式